Table 3. Characteristics of the conservative treatment group versus the secondary procedure group after ET failure.
| Characteristic | Conservative treatment | 2nd Procedure | p-value |
|---|---|---|---|
| Ureters | 43 | 33 | |
| Indications for ET | 0.309 | ||
| Breakthrough UTI | 39 (57.4) | 29 (42.6) | |
| Decreased renal function or newly developed renal scar | 3 (50.0) | 3 (50.0) | |
| Noncompliance with medication | 2 (100) | 0 (0) | |
| VUR grade | 2.93±0.99 | 3.37±0.75 | 0.038 |
| Mound morphology | <0.001 | ||
| Volcano shape | 34 (77.3) | 10 (22.7) | |
| Other shape | 10 (31.2) | 22 (68.8) | |
| Postoperative US finding of mound in bladder | 0.163 | ||
| Visualized | 26 (66.7) | 13 (33.3) | |
| Not visualized | 18 (48.7) | 19 (51.4) | |
| IDC | 0.025 | ||
| Normal | 35 (63.6) | 20 (36.4) | |
| Positive IDC | 2 (22.2) | 7 (77.8) |
Values are presented as number (%) or mean±standard deviation.
ET, endoscopic treatment; UTI, urinary tract infection, VUR, vesicoureteral reflux; US, ultrasonography; IDC, involuntary detrusor contraction.